Abeona Therapeutics (ABEO) Return on Equity (2016 - 2025)
Historic Return on Equity for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.21%.
- Abeona Therapeutics' Return on Equity rose 10700.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 10700.0%. This contributed to the annual value of 2.32% for FY2024, which is 400.0% down from last year.
- Latest data reveals that Abeona Therapeutics reported Return on Equity of 0.21% as of Q3 2025, which was up 10700.0% from 0.39% recorded in Q2 2025.
- Abeona Therapeutics' 5-year Return on Equity high stood at 0.39% for Q2 2025, and its period low was 17.06% during Q1 2024.
- In the last 5 years, Abeona Therapeutics' Return on Equity had a median value of 1.53% in 2021 and averaged 2.76%.
- Per our database at Business Quant, Abeona Therapeutics' Return on Equity tumbled by -151700bps in 2024 and then surged by 156200bps in 2025.
- Abeona Therapeutics' Return on Equity (Quarter) stood at 1.53% in 2021, then plummeted by -72bps to 2.64% in 2022, then grew by 2bps to 2.58% in 2023, then skyrocketed by 52bps to 1.24% in 2024, then skyrocketed by 117bps to 0.21% in 2025.
- Its Return on Equity was 0.21% in Q3 2025, compared to 0.39% in Q2 2025 and 1.44% in Q1 2025.